Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma
- PMID: 25986316
- DOI: 10.1177/1203475415586664
Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma
Erratum in
- J Cutan Med Surg. 2015 Nov-Dec;19(6):604
-
Corrigendum.J Cutan Med Surg. 2015 Nov-Dec;19(6):604. doi: 10.1177/1203475415610304. Epub 2015 Sep 28. J Cutan Med Surg. 2015. PMID: 26416982 No abstract available.
Abstract
Background: Basal cell carcinoma (BCC) is the most common malignancy. Growth of BCCs leads to local destruction of neighbouring healthy skin and underlying tissue and can result in significant functional and cosmetic morbidity.
Objective: To provide guidance to Canadian health care practitioners regarding management of BCCs.
Methods: Literature searches and development of graded recommendations were carried out as discussed in the accompanying Introduction.
Results: Although BCCs rarely metastasize, they can be aggressive and disfiguring. This chapter describes the natural history and prognosis of BCCs. Risk stratification is based on clinical features, including the site and size of the tumour, its histologic subtype (nodular vs sclerosing), and its history of recurrence.
Conclusions: Various options should be considered for BCC treatment, including cryosurgery, curettage, and topical or photodynamic approaches, as well as fixed-margin surgery and Mohs micrographic surgery. Stratification of recurrence risk for individual BCCs determines the most appropriate therapeutic course.
Keywords: Mohs micrographic surgery; basal cell carcinoma; cryosurgery; photodynamic therapy; radiation therapy; surgical margin.
© The Author(s) 2015.
Similar articles
-
Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma.J Cutan Med Surg. 2015 May-Jun;19(3):249-59. doi: 10.1177/1203475415582318. Epub 2015 Apr 28. J Cutan Med Surg. 2015. PMID: 25922470
-
Basal cell carcinoma--new aspects of diagnosis and treatment.Acta Derm Venereol Suppl (Stockh). 2000;209:5-25. Acta Derm Venereol Suppl (Stockh). 2000. PMID: 10884941 Review.
-
The effective treatment of basal cell carcinoma.Br J Nurs. 2009 Mar 26-Apr 8;18(6):346, 348-50. doi: 10.12968/bjon.2009.18.6.40766. Br J Nurs. 2009. PMID: 19329898 Review.
-
Rapid wound re-epithelialization and basal cell carcinoma clearance after Mohs micrographic surgery with postoperative photodynamic therapy.J Drugs Dermatol. 2010 Feb;9(2):143-8. J Drugs Dermatol. 2010. PMID: 20214177
-
Basal cell carcinoma: an evidence-based treatment update.Am J Clin Dermatol. 2014 Jul;15(3):197-216. doi: 10.1007/s40257-014-0070-z. Am J Clin Dermatol. 2014. PMID: 24733429 Review.
Cited by
-
A Conservative Combined Laser Cryoimmunotherapy Treatment vs. Surgical Excision for Basal Cell Carcinoma.J Clin Med. 2022 Jun 15;11(12):3439. doi: 10.3390/jcm11123439. J Clin Med. 2022. PMID: 35743507 Free PMC article.
-
Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.Curr Oncol. 2019 Apr;26(2):114-118. doi: 10.3747/co.26.4557. Epub 2019 Apr 1. Curr Oncol. 2019. PMID: 31043813 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical